| Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity CK Wong, LCW Lit, LS Tam, EKM Li, PTY Wong, CWK Lam Clinical immunology 127 (3), 385-393, 2008 | 761 | 2008 |
| The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors DS Hui, KT Wong, FW Ko, LS Tam, DP Chan, J Woo, JJY Sung Chest 128 (4), 2247-2261, 2005 | 445 | 2005 |
| Accrual of organ damage over time in patients with systemic lupus erythematosus. DD Gladman, MB Urowitz, P Rahman, D Ibañez, LS Tam The Journal of rheumatology 30 (9), 1955-1959, 2003 | 396 | 2003 |
| Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus P Rahman, DD Gladman, MB Urowitz, D Hallett, LS Tam Lupus 10 (2), 93-96, 2001 | 344 | 2001 |
| Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study D Baeten, M Østergaard, JCC Wei, J Sieper, P Järvinen, LS Tam, ... Annals of the rheumatic diseases 77 (9), 1295-1302, 2018 | 333 | 2018 |
| Cardiovascular risk profile of patients with psoriatic arthritis compared to controls—the role of inflammation LS Tam, B Tomlinson, TTW Chu, M Li, YY Leung, LW Kwok, TK Li, T Yu, ... Rheumatology 47 (5), 718-723, 2008 | 332 | 2008 |
| Pathogenesis of ankylosing spondylitis LS Tam, J Gu, D Yu Nature Reviews Rheumatology 6 (7), 399-405, 2010 | 306 | 2010 |
| Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis LS Tam, B Tomlinson, TT Chu, TK Li, EK Li Clinical rheumatology 26, 1495-1498, 2007 | 275 | 2007 |
| Imbalance of Th1/Th2 transcription factors in patients with lupus nephritis RWY Chan, FMM Lai, EKM Li, LS Tam, KM Chow, PKT Li, CC Szeto Rheumatology 45 (8), 951-957, 2006 | 248 | 2006 |
| Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus LCW Lit, CK Wong, LS Tam, EKM Li, CWK Lam Annals of the rheumatic diseases 65 (2), 209-215, 2006 | 240 | 2006 |
| Serum and urinary cell–free MiR-146a and MiR-155 in patients with systemic lupus erythematosus G Wang, LS Tam, EKM Li, BCH Kwan, KM Chow, CCW Luk, PKT Li, ... The Journal of rheumatology 37 (12), 2516-2522, 2010 | 236 | 2010 |
| IL33: roles in allergic inflammation and therapeutic perspectives BCL Chan, CWK Lam, LS Tam, CK Wong Frontiers in immunology 10, 394368, 2019 | 234 | 2019 |
| Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection LS Tam, AYK Chan, PKS Chan, AR Chang, EK Li Arthritis & Rheumatism 50 (11), 3619-3625, 2004 | 211 | 2004 |
| Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus CK Wong, LCW Lit, LS Tam, EK Li, CWK Lam Rheumatology 44 (8), 989-994, 2005 | 193 | 2005 |
| Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong LS Tam, EK Li, SM Wong, CC Szeto Scandinavian journal of rheumatology 31 (5), 296-300, 2002 | 187 | 2002 |
| Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement P Nash, A Kerschbaumer, T Dörner, M Dougados, RM Fleischmann, ... Annals of the rheumatic diseases 80 (1), 71-87, 2021 | 184 | 2021 |
| Serum and urinary free microRNA level in patients with systemic lupus erythematosus G Wang, LS Tam, EKM Li, BCH Kwan, KM Chow, CCW Luk, PKT Li, ... Lupus 20 (5), 493-500, 2011 | 183 | 2011 |
| Subclinical carotid atherosclerosis in patients with psoriatic arthritis LS Tam, Q Shang, EK Li, B Tomlinson, TTW Chu, M Li, YY Leung, ... Arthritis Care & Research: Official Journal of the American College of …, 2008 | 176 | 2008 |
| Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus LW Kwok, LS Tam, TY Zhu, YY Leung, EK Li Lupus 20 (8), 829-836, 2011 | 175 | 2011 |
| Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus LS Tam, EK Li, CK Wong, CWK Lam, CC Szeto Lupus 13 (8), 601-604, 2004 | 172 | 2004 |
